It inhibits M1-polarization and IFN-β production, and p50-deficient mice show exacerbated M1-driven inflammation and defective capacity to mount allergy-driven M2-polarized inflammatory reactions [57]. This evidence concerns the gene IFNB1 and allergic disease.